Challenge of the two neural tumors: neuroblastoma and retinoblastoma.
Southeast Asian J Trop Med Public Health
;
1985 Dec; 16(4): 681-7
Article
in English
| IMSEAR
| ID: sea-35948
ABSTRACT
Fifty cases of neuroblastoma and 29 retinoblastoma patients who had additional chemotherapy were analyzed retrospectively. MaleFemale ratio were 11 and 0.81, the ages ranged from birth to 14 years (4 +/- 3.42 year) for neuroblastoma, and one month to 5.5 years (2.4 +/- 1.4 year) for retinoblastoma. More than 70%-90% of them came in advanced stages. The treatment consisted of surgical resection, enucleation or exenteration if feasible. Radiation therapy and chemotherapy were given as specific and palliative measures. All of the neuroblastoma who were younger than 8 months old survived long-term. Various chemotherapeutic agents did not seem to effect the outcome of the advanced cases of these two diseases. The retinoblasts did not seem to be sensitive to MTX and Ara-C. Thio-tepa intrathecally seems to be worth trying. Since these two tumors are not sensitive to treatment and are still a great challenge to the developed countries, awareness of the diseases, early diagnosis and early treatment are appropriate approaches for the developing countries.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Retinoblastoma
/
Female
/
Humans
/
Male
/
Infant, Newborn
/
Antineoplastic Combined Chemotherapy Protocols
/
Child
/
Child, Preschool
/
Adolescent
/
Combined Modality Therapy
Type of study:
Screening study
Language:
English
Journal:
Southeast Asian J Trop Med Public Health
Year:
1985
Type:
Article
Similar
MEDLINE
...
LILACS
LIS